World's Best Scientists 2026 revealed!
Christian P. Larsen

Christian P. Larsen

D-Index & Metrics

Immunology

D-Index
95
Citations
36057
World Ranking
890
National Ranking
494

Medicine

D-Index
95
Citations
36126
World Ranking
9999
National Ranking
5147

Christian P. Larsen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Christian P. Larsen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 370 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Christian P. Larsen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Christian P. Larsen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 95 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Christian P. Larsen is affiliated with Emory University in the United States and has focused primarily on medical research with significant contributions in transplantation, infectious diseases, and immunology. Their work spans various subfields, including transplantation, infectious diseases, immunology, epidemiology, and surgery.

The main areas of research addressed by Larsen include renal transplantation outcomes and treatments, cytomegalovirus and herpesvirus research, immune cell function and interaction, SARS-CoV-2 and COVID-19 research, T-cell and B-cell immunology, COVID-19 clinical research studies, and Pneumocystis jirovecii pneumonia detection and treatment.

Frequent coauthors collaborating with Larsen are:

  • Geeta Karadkhele
  • Haydn Kissick
  • I.R. Badell
  • Aileen C. Johnson
  • Stephanie M. Pouch

Common publication venues where Larsen has published multiple articles include:

  • American Journal of Transplantation
  • Open Forum Infectious Diseases
  • Clinical Transplantation
  • Transplant Infectious Disease
  • Transplantation Direct

Examples of notable recent papers authored by Larsen include:

  • CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor, 2022, Immunity
  • Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes, 2020, American Journal of Transplantation
  • Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement, 2023, Science Translational Medicine
  • CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept, 2020, American Journal of Transplantation
  • Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry, 2023, The Lancet Diabetes & Endocrinology

Larsen's research contributions have demonstrated engagement with clinical trial design, infectious disease control in transplant recipients, immune cell functionality, and long-term transplantation outcomes. The focus on cytomegalovirus, immune responses, and transplantation reflects a comprehensive approach integrating immunology with clinical patient care.

Best Publications

  • Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.

    Christian P. Larsen;Eric T. Elwood;Diane Z. Alexander;Shannon C. Ritchie

  • mTOR regulates memory CD8 T-cell differentiation

    Koichi Araki;Alexandra P. Turner;Virginia Oliva Shaffer;Shivaprakash Gangappa

  • Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

    Jens Wrammert;Kenneth Smith;Joe Miller;William A. Langley

  • A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

    F. Vincenti;B. Charpentier;Y. Vanrenterghem;L. Rostaing

  • Costimulation blockade with belatacept in renal transplantation.

    Flavio Vincenti;Christian Larsen;Antoine Durrbach;Thomas Wekerle

  • 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.

    Walter W. Shuford;Kerry Klussman;Douglas D. Tritchler;Deryk T. Loo

  • Improvement in outcomes of clinical islet transplantation: 1999-2010.

    Franca B. Barton;Michael R. Rickels;Rodolfo Alejandro;Bernhard J. Hering

  • Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties

    Christian P. Larsen;Thomas C. Pearson;Andrew B. Adams;Paul Tso

  • Migration and maturation of Langerhans cells in skin transplants and explants.

    C P Larsen;R M Steinman;M Witmer-Pack;D F Hankins

  • Belatacept and Long-Term Outcomes in Kidney Transplantation.

    Flavio Vincenti;Lionel Rostaing;Joseph Grinyo;Kim Rice

  • Heterologous immunity provides a potent barrier to transplantation tolerance.

    Andrew B. Adams;Matthew A. Williams;Thomas R. Jones;Nozomu Shirasugi

  • Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia

    Bernhard J. Hering;William R. Clarke;Nancy D. Bridges;Thomas L. Eggerman

  • Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection.

    C P Larsen;P J Morris;J M Austyn

  • Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1.

    Justin A. Roake;Abdul S. Rao;Peter J. Morris;Christian P. Larsen

  • Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways.

    Kenneth Cardona;Gregory S Korbutt;Zvonimir Milas;James Lyon

  • Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells.

    C P Larsen;S C Ritchie;R Hendrix;P S Linsley

  • Transplantation tolerance induced by CTLA4-Ig.

    Thomas C. Pearson;Diane Z. Alexander;Kevin J. Winn;Peter S. Linsley

  • CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway

    Christian P. Larsen;Diane Z. Alexander;Diane Hollenbaugh;Eric T. Elwood

  • Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.

    F. Vincenti;C. P. Larsen;J. Alberu;B. Bresnahan

  • Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations

    C P Larsen;S C Ritchie;T C Pearson;P S Linsley

Frequent Co-Authors

Thomas C. Pearson
Thomas C. Pearson Emory University
Allan D. Kirk
Allan D. Kirk Duke University
Mandy L. Ford
Mandy L. Ford Emory University
Flavio Vincenti
Flavio Vincenti University of California, San Francisco
Rafi Ahmed
Rafi Ahmed Emory University
Peter S. Linsley
Peter S. Linsley Benaroya Research Institute
Keith A. Reimann
Keith A. Reimann Harvard Medical School
Diane Hollenbaugh
Diane Hollenbaugh Bonum Therapeutics
Josep M. Grinyó
Josep M. Grinyó University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can open additional career opportunities. One such pathway is becoming a Nurse Practitioner, where programs vary in rigor and focus. If you're looking for flexible options, researching the easiest nurse practitioner program might help you find a program that balances quality and accessibility.

Mental health specialties are increasingly vital, linking closely with immunological health. Online Psychiatric-Mental Health Nurse Practitioner (PMHNP) programs are a popular choice. Ensuring strong practical experience is key, so considering pmhnp programs online with best clinical placement can significantly enhance your hands-on training.

Cost is another important factor. Many students pursue affordable pmhnp programs that provide quality education without excessive debt. Balancing affordability with program outcomes ensures you make a smart financial decision.

Advanced practice nurses often pursue Doctor of Nursing Practice (DNP) degrees. Within this realm, some specialties are more lucrative. To gauge potential earnings, review data on the highest paid dnp specialties, which can guide your career planning after completing your degree.

Best Scientists Citing Christian P. Larsen

Trending Scientists

Recently Published Articles